Insider · CIK 0001213041

GRAMMER ELIZABETH A

Reports to the SEC for 2 companies · SAN MATEO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001213041

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-12	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+39.6K sh	—	—	39,567
2025-11-21	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−5,995 sh	$5.54	−$33.2K	299,895
2025-08-21	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−5,841 sh	$5.93	−$34.6K	305,890
2025-06-09	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32.3K sh	—	—	32,250
2025-05-20	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−5,992 sh	$4.08	−$24.5K	311,731
2025-02-25	ARDXARDELYX, INC.A Award	See Remarks	AAward	+137K sh	—	—	317,723
2025-02-25	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+205K sh	—	—	205,019
2025-02-20	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−4,291 sh	$5.62	−$24.1K	181,043
2024-11-20	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−7,046 sh	$4.79	−$33.8K	185,334
2024-08-20	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−7,089 sh	$5.86	−$41.5K	192,380
2024-06-05	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+51.5K sh	—	—	51,459
2024-05-21	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−6,927 sh	$7.81	−$54.1K	199,469
2024-05-06	ARDXARDELYX, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+110K sh	$0.99	+$109K	378,243
2024-05-06	ARDXARDELYX, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+110K sh	$2.75	+$302K	487,930
2024-05-06	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−64.2K sh	$8.87	−$570K	423,697
2024-05-06	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−220K sh	$8.88	−$1.95M	203,760
2024-05-06	ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−110K sh	—	—	85,750
2024-05-06	ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−110K sh	—	—	241,313
2024-05-03	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−45K sh	$9.00	−$405K	267,993
2024-03-20	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−86K sh	$7.73	−$665K	312,993
2024-02-20	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−4,432 sh	$8.75	−$38.8K	398,993
2024-01-16	ARDXARDELYX, INC.A Award	See Remarks	AAward	+128K sh	—	—	403,425
2024-01-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+164K sh	—	—	164,000
2023-12-11	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−50K sh	$5.08	−$254K	275,675
2023-11-20	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−2,384 sh	$4.36	−$10.4K	325,675
2023-08-21	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−2,392 sh	$3.55	−$8,495.906	328,059
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−49.5K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+49.5K sh	—	—	49,533
2023-05-23	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−2,384 sh	$3.65	−$8,709.229	330,451
2023-02-21	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−2,914 sh	$3.00	−$8,744.914	329,954
2023-01-05	ARDXARDELYX, INC.A Award	See Remarks	AAward	+78K sh	—	—	332,868
2023-01-05	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+351K sh	—	—	351,000
2022-11-22	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−29 sh	$1.94	−$56.304	256,081
2022-11-22	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−20 sh	$1.95	−$38.9	256,061
2022-11-22	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−1,193 sh	$1.95	−$2,325.515	254,868
2022-08-31	ARDXARDELYX, INC.P Purchase	See Remarks	PPurchase	+3,000 sh	$0.62	+$1,856.4	256,110
2022-08-22	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−1,225 sh	$0.98	−$1,205.033	253,121
2022-08-22	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−2 sh	$0.98	−$1.96	253,119
2022-08-22	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−9 sh	$0.98	−$8.822	253,110
2022-06-06	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−59.6K sh	$0.65	−$38.8K	255,606
2022-06-06	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−1,260 sh	$0.64	−$800.856	254,346
2022-05-20	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−1,263 sh	$0.67	−$847.978	315,167
2022-02-22	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−1,528 sh	$0.67	−$1,023.76	316,430
2022-01-06	ARDXARDELYX, INC.A Award	See Remarks	AAward	+42K sh	—	—	317,958
2022-01-06	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+196K sh	—	—	196,000
2021-11-22	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−537 sh	$0.99	−$532.65	275,958
2021-11-12	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−77.4K sh	$1.13	−$87.1K	276,495
2021-10-08	ARDXARDELYX, INC.A Award	See Remarks	AAward	−250K sh	—	—	353,927
2021-08-20	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−526 sh	$1.32	−$694.32	102,386
2021-05-20	ARDXARDELYX, INC.S Sale	See Remarks	SSale	−508 sh	$7.09	−$3,600.602	102,912

Recent filings

Accepted (ET)
Jun 154
GRAMMER ELIZABETH A0001104659-26-074047
SEC(opens sec.gov)
Nov 254
GRAMMER ELIZABETH A0001610717-25-000397
SEC(opens sec.gov)
Aug 254
GRAMMER ELIZABETH A0001628280-25-041131
SEC(opens sec.gov)
Jun 104
GRAMMER ELIZABETH A0001104659-25-058220
SEC(opens sec.gov)
May 224
GRAMMER ELIZABETH A0001628280-25-027425
SEC(opens sec.gov)
Feb 274
GRAMMER ELIZABETH A0001628280-25-008792
SEC(opens sec.gov)
Feb 214
GRAMMER ELIZABETH A0001628280-25-007228
SEC(opens sec.gov)
Nov 224
GRAMMER ELIZABETH A0001628280-24-049049
SEC(opens sec.gov)
Aug 224
GRAMMER ELIZABETH A0001628280-24-038287
SEC(opens sec.gov)
Jun 74
GRAMMER ELIZABETH A0001104659-24-069626
SEC(opens sec.gov)
May 234
GRAMMER ELIZABETH A0001628280-24-024935
SEC(opens sec.gov)
May 94
GRAMMER ELIZABETH A0001610717-24-000235
SEC(opens sec.gov)
May 74
GRAMMER ELIZABETH A0001610717-24-000233
SEC(opens sec.gov)
Mar 224
GRAMMER ELIZABETH A0001610717-24-000182
SEC(opens sec.gov)

Companies

Address

SAGIMET BIOSCIENCES INC. 155 BOVET ROAD, SUITE 303

SAN MATEO, CA, 94402